Biotech Startup Claims It’s Getting Closer to ‘Resurrecting’ the Extinct Dodo

Colossal Biosciences, a biotech startup, claims to be making progress towards "resurrecting" the extinct dodo bird. The company believes it can functionally restore the dodo within the next 5 to 7 years, based on its recent advancements. The dodo, a flightless bird native to the island of Mauritius, went extinct in the 17th century due to human activity and the introduction of invasive species. Colossal Biosciences aims to use advanced genetic engineering techniques, such as CRISPR, to recover the dodo's DNA and potentially bring the species back to life. While the company's claims are ambitious, the feasibility and ethical implications of "de-extinction" efforts remain subject to debate within the scientific community. Experts have raised concerns about the potential ecological impact and the philosophical questions surrounding the resurrection of extinct species. Colossal Biosciences' announcement highlights the rapidly evolving field of biotechnology and the ongoing pursuit of innovative solutions to restore biodiversity and address the global extinction crisis.